ACTIVITIES OF (-)-CARBOVIR AND 3'-AZIDO-3'-DEOXYTHYMIDINE AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS INVITRO

被引:22
作者
CARTER, SG
KESSLER, JA
RANKIN, CD
机构
[1] Division of Chemotherapy, Glaxo Research Laboratories, Glaxo Inc., Research Triangle Park, NC
关键词
D O I
10.1128/AAC.34.6.1297
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
(-)-Carbovir, the minus optical isomer of carbocyclic-2',3'-didehydro-2',3'-dideoxyguanosine, has been shown to be the biologically active form for the inhibition of human immunodeficiency virus type 1 replication. The concentration of (-)-carbovir required to reduce reverse transcriptase activity by 50% compared with the control was 0.8 μM in H9 cells infected with the HTLV-IIIb strain; the 50% inhibitory concentration for cytotoxicity was > 2 mM in these cells. The effect of the timing of drug addition, pre- and postinfection, and the effect of increasing amounts of virus on the antiviral activities of (-)-carbovir and 3'-azido-3'-deoxythymidine were determined.
引用
收藏
页码:1297 / 1300
页数:4
相关论文
共 23 条
  • [1] INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYINOSINE, AN INHIBITOR OF HIV INFECTIVITY
    AHLUWALIA, G
    COONEY, DA
    MITSUYA, H
    FRIDLAND, A
    FLORA, KP
    HAO, Z
    DALAL, M
    BRODER, S
    JOHNS, DG
    [J]. BIOCHEMICAL PHARMACOLOGY, 1987, 36 (22) : 3797 - 3800
  • [2] ALLEY MC, 1988, CANCER RES, V48, P589
  • [3] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
    BARRESINOUSSI, F
    CHERMANN, JC
    REY, F
    NUGEYRE, MT
    CHAMARET, S
    GRUEST, J
    DAUGUET, C
    AXLERBLIN, C
    VEZINETBRUN, F
    ROUZIOUX, C
    ROZENBAUM, W
    MONTAGNIER, L
    [J]. SCIENCE, 1983, 220 (4599) : 868 - 871
  • [4] A PATHOGENIC RETROVIRUS (HTLV-III) LINKED TO AIDS
    BRODER, S
    GALLO, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (20) : 1292 - 1297
  • [5] THE EFFICACY OF AZIDOTHYMIDINE (AZT) IN THE TREATMENT OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    FISCHL, MA
    RICHMAN, DD
    GRIECO, MH
    GOTTLIEB, MS
    VOLBERDING, PA
    LASKIN, OL
    LEEDOM, JM
    GROOPMAN, JE
    MILDVAN, D
    SCHOOLEY, RT
    JACKSON, GG
    DURACK, DT
    KING, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) : 185 - 191
  • [6] HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III SHARES SEQUENCE HOMOLOGY WITH A FAMILY OF PATHOGENIC LENTIVIRUSES
    GONDA, MA
    BRAUN, MJ
    CLEMENTS, JE
    PYPER, JM
    WONGSTAAL, F
    GALLO, RC
    GILDEN, RV
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (11) : 4007 - 4011
  • [7] HAGLER DN, 1986, LANCET, V2, P1392
  • [8] LIN TS, 1987, BIOCHEM PHARMACOL, V36, P2713
  • [10] 3'-AZIDO-3'-DEOXYTHYMIDINE (BW A509U) - AN ANTIVIRAL AGENT THAT INHIBITS THE INFECTIVITY AND CYTOPATHIC EFFECT OF HUMAN LYMPHOTROPIC-T VIRUS TYPE-III LYMPHADENOPATHY-ASSOCIATED VIRUS INVITRO
    MITSUYA, H
    WEINHOLD, KJ
    FURMAN, PA
    STCLAIR, MH
    LEHRMAN, SN
    GALLO, RC
    BOLOGNESI, D
    BARRY, DW
    BRODER, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (20) : 7096 - 7100